Alatzoglou, F.-E.G.; Vassaki, M.; Nirgianaki, K.; Tripodianos, E.; Turhanen, P.; Demadis, K.D.; Papathanasiou, K.E.
Surface-Modified Silica Hydrogels for the Programmable Release of Bisphosphonate Anti-Osteoporosis Drugs: The Case of Etidronate. Materials 2023, 16, 3379.
https://doi.org/10.3390/ma16093379
AMA Style
Alatzoglou F-EG, Vassaki M, Nirgianaki K, Tripodianos E, Turhanen P, Demadis KD, Papathanasiou KE.
Surface-Modified Silica Hydrogels for the Programmable Release of Bisphosphonate Anti-Osteoporosis Drugs: The Case of Etidronate. Materials. 2023; 16(9):3379.
https://doi.org/10.3390/ma16093379
Chicago/Turabian Style
Alatzoglou, Fanouria-Eirini G., Maria Vassaki, Kalliopi Nirgianaki, Eleftherios Tripodianos, Petri Turhanen, Konstantinos D. Demadis, and Konstantinos E. Papathanasiou.
2023. "Surface-Modified Silica Hydrogels for the Programmable Release of Bisphosphonate Anti-Osteoporosis Drugs: The Case of Etidronate" Materials 16, no. 9: 3379.
https://doi.org/10.3390/ma16093379
APA Style
Alatzoglou, F.-E. G., Vassaki, M., Nirgianaki, K., Tripodianos, E., Turhanen, P., Demadis, K. D., & Papathanasiou, K. E.
(2023). Surface-Modified Silica Hydrogels for the Programmable Release of Bisphosphonate Anti-Osteoporosis Drugs: The Case of Etidronate. Materials, 16(9), 3379.
https://doi.org/10.3390/ma16093379
